CNS Pharmaceuticals, Inc. Annual Interest Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from 2018 to 2023.
  • CNS Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $6.63K, a 21.9% increase year-over-year.
  • CNS Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $15K, a 51.5% increase year-over-year.
  • CNS Pharmaceuticals, Inc. annual Interest Expense for 2023 was $13.8K, a 96.5% increase from 2022.
  • CNS Pharmaceuticals, Inc. annual Interest Expense for 2022 was $7.03K, a 24.3% decline from 2021.
  • CNS Pharmaceuticals, Inc. annual Interest Expense for 2021 was $9.29K, a 184% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.8K +$6.78K +96.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $7.03K -$2.26K -24.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $9.29K +$6.02K +184% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $3.26K -$22.9K -87.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 $26.2K -$2.46K -8.61% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-12
2018 $28.6K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.